Literature DB >> 26629275

Sivextro (Tedizolid Phosphate) Approved for the Treatment of Adults with Acute Bacterial Skin and Skin-Structure Infections.

Loretta Fala.   

Abstract

Entities:  

Year:  2015        PMID： 26629275      PMCID： PMC4665048     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN： 1942-2962


× No keyword cloud information.
  8 in total

1.  Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA.

Authors:  Heather A Carleton; Binh An Diep; Edwin D Charlebois; George F Sensabaugh; Françoise Perdreau-Remington
Journal:  J Infect Dis       Date:  2004-10-18       Impact factor: 5.226

2.  The attributable clinical and economic burden of skin and skin structure infections in hospitalized patients: a matched cohort study.

Authors:  Hind T Hatoum; Kasem S Akhras; Swu-Jane Lin
Journal:  Diagn Microbiol Infect Dis       Date:  2009-07       Impact factor: 2.803

3.  Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.

Authors:  Gregory J Moran; Edward Fang; G Ralph Corey; Anita F Das; Carisa De Anda; Philippe Prokocimer
Journal:  Lancet Infect Dis       Date:  2014-06-05       Impact factor: 25.071

Review 4.  Acute bacterial skin infections and cellulitis.

Authors:  Marion Gabillot-Carré; Jean-Claude Roujeau
Journal:  Curr Opin Infect Dis       Date:  2007-04       Impact factor: 4.915

5.  The impact of antimicrobial resistance on health and economic outcomes.

Authors:  Sara E Cosgrove; Yehuda Carmeli
Journal:  Clin Infect Dis       Date:  2003-05-16       Impact factor: 9.079

6.  Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial.

Authors:  Philippe Prokocimer; Carisa De Anda; Edward Fang; Purvi Mehra; Anita Das
Journal:  JAMA       Date:  2013-02-13       Impact factor: 56.272

Review 7.  Tedizolid phosphate for the management of acute bacterial skin and skin structure infections: efficacy summary.

Authors:  William O'Riordan; Sinikka Green; Purvi Mehra; Carisa De Anda; Edward Fang; Philippe Prokocimer
Journal:  Clin Infect Dis       Date:  2014-01       Impact factor: 9.079

8.  Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005.

Authors:  Eili Klein; David L Smith; Ramanan Laxminarayan
Journal:  Emerg Infect Dis       Date:  2007-12       Impact factor: 6.883
  8 in total
  2 in total

Review 1.  Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms.

Authors:  Despoina Koulenti; Elena Xu; Isaac Yin Sum Mok; Andrew Song; Drosos E Karageorgopoulos; Apostolos Armaganidis; Jeffrey Lipman; Sotirios Tsiodras
Journal:  Microorganisms       Date:  2019-08-18

2.  Coexistence of the Oxazolidinone Resistance-Associated Genes cfr and optrA in Enterococcus faecalis From a Healthy Piglet in Brazil.

Authors:  Lara M Almeida; Anthony Gaca; Paulo M Bispo; François Lebreton; Jose T Saavedra; Rafael A Silva; Irinaldo D Basílio-Júnior; Felipe M Zorzi; Pedro H Filsner; Andrea M Moreno; Michael S Gilmore
Journal:  Front Public Health       Date:  2020-09-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.